ACTIVE

FREPIMON

Financial year 2025 · closed on 30/06/2025
Net result
-55 k €
+30.6% YoY
Gross margin
32,2 k €
+284.1% YoY
Equity
496,8 k €
-10.0% YoY

What does FREPIMON do?

FREPIMON is a Public limited company incorporated in 1992. Its registered office is in Spiere-Helkijn.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0447.813.168
Incorporation
03/07/1992
Legal form
Public limited company
Registered office
Chée d'Audenaerde 31
8587 Spiere-Helkijn · FlandreSee on map
Contributed capital
670 848,00 €
Latest accounts
30/06/2025
Joint committees (1)
  • 313
Signals
Solid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 17 financial years

20252024202320222019201820172016201520142013201220112010200920082007
Income statement
Gross margin32,2 k €8,4 k €9,1 k €4,5 k €10,7 k €13,8 k €526 €4,7 k €572,5 €-1,9 k €5,8 k €4,3 k €5,3 k €-9,4 k €3,7 k €-12,9 k €36,9 k €
EBITDA6,3 k €3 k €4,6 k €148,6 €5,6 k €8,8 k €-3,5 k €691 €-3,4 k €-5,8 k €2 k €860 €1,9 k €-12,8 k €381 €-16,8 k €34,3 k €
Operating result-59,4 k €-68 k €-58,3 k €-62,7 k €-3,8 k €-659,1 €-12,9 k €-9,2 k €-13,3 k €-15,8 k €-8,2 k €-9,3 k €-8 k €-23,1 k €-9,7 k €-27,4 k €23,7 k €
Net result-55 k €-79,3 k €-66,6 k €-69,5 k €17 k €25,6 k €13,7 k €16,5 k €14,8 k €14,4 k €20,4 k €18,5 k €16,6 k €1,4 k €14,7 k €-2,9 k €17 k €
Balance sheet
Equity496,8 k €551,8 k €631,1 k €697,7 k €782 k €765,8 k €740,2 k €726,5 k €710 k €695,2 k €746,3 k €725,9 k €707,3 k €707,3 k €707,3 k €704,5 k €707,3 k €
Total assets704,9 k €770,2 k €844,1 k €911,6 k €896,9 k €895,2 k €852,8 k €832,5 k €816,8 k €789,3 k €770,4 k €742,4 k €731,5 k €715,3 k €729,8 k €715,7 k €738,8 k €
Cash115,7 k €175,1 k €371,1 k €382,6 k €15,5 k €32,3 k €10,1 k €10,2 k €11,6 k €9,4 k €10,9 k €14,2 k €24,4 k €25 k €55,7 k €31,6 k €13,9 k €
Debts206,4 k €203,1 k €202 k €204,6 k €109,8 k €124,4 k €112,6 k €101,5 k €102,4 k €94,1 k €24,1 k €16,5 k €24,1 k €7,9 k €20,5 k €10,2 k €31,4 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation
Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 18 ended

Active mandates

Maria Vanneste

Director · since 30 janvier 2020 · until 30 janvier 2026

Active

Ended mandates

Maria Vanneste

Director · since 30 janvier 2020

Ended
Apotheek Hermes

Director · since 13 novembre 2013 · 0423.649.379

Represented by Maria Vanneste

Ended
Invest Vandeputte-Vanneste

Director · since 13 novembre 2013 · 0880.281.532

Represented by Maria Vanneste

Ended
Maria Vanneste

Managing director · since 13 novembre 2013

Ended
At this address

Other companies at this address

CompanyCBE no.
0438.291.629
VDPharmacyActive
0637.870.020
Annual accounts

Full financial information

202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelAbridged modelAbridged model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date16/12/202518/12/202421/12/202323/12/202231/01/202208/01/2021
General meeting11/12/202512/12/202414/12/202308/12/202230/12/202110/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

20 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202511/12/202516/12/2025DutchPDF
Micro model30/06/202412/12/202418/12/2024DutchPDF
Micro model30/06/202314/12/202321/12/2023DutchPDF
Micro model30/06/202208/12/202223/12/2022DutchPDF
Abridged model30/06/202130/12/202131/01/2022DutchPDF
Abridged model30/06/202010/12/202008/01/2021DutchPDF
Abridged model30/06/201930/09/201921/10/2019DutchPDF
Abridged model30/06/201813/12/201821/12/2018DutchPDF
Abridged model30/06/201714/12/201715/01/2018DutchPDF
Abridged model30/06/201629/12/201612/01/2017DutchPDF
Abridged model30/06/201517/12/201515/01/2016DutchPDF
Abridged model30/06/201411/12/201416/01/2015DutchPDF
Abridged model30/06/201316/01/201425/02/2014DutchPDF
Abridged model30/06/201217/01/201314/02/2013DutchPDF
Abridged model30/06/201129/12/201126/01/2012DutchPDF
Abridged model30/06/201030/12/201028/01/2011DutchPDF
Abridged model30/06/200910/12/200908/01/2010DutchPDF
Abridged model30/06/200811/12/200822/12/2008DutchPDF
Abridged model30/06/200703/01/200825/01/2008DutchPDF
Abridged model30/06/200625/01/200720/02/2007DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 18 ended

Active mandates

Maria Vanneste

Director · since 30 janvier 2020 · until 30 janvier 2026

Active

Ended mandates

Maria Vanneste

Director · since 30 janvier 2020

Ended
Apotheek Hermes

Director · since 13 novembre 2013 · 0423.649.379

Represented by Maria Vanneste

Ended
Invest Vandeputte-Vanneste

Director · since 13 novembre 2013 · 0880.281.532

Represented by Maria Vanneste

Ended
Maria Vanneste

Managing director · since 13 novembre 2013

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Restructuring19/02/2020
    KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring06/01/2020
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates27/11/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares21/08/2014
    KAPITAAL - AANDELEN
    PDF
  • Mandates11/12/2013
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/02/2012
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates06/12/2006
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/02/2006
    ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-55 k €
  2. 2024
    Annual accounts 2024-79,3 k €
  3. 2023
    Annual accounts 2023-66,6 k €
  4. 2022
    Annual accounts 2022-69,5 k €
  5. 2019
    Annual accounts 201917 k €
  6. 2018
    Annual accounts 201825,6 k €
  7. 2017
    Annual accounts 201713,7 k €
  8. 2016
    Annual accounts 201616,5 k €
  9. 2015
    Annual accounts 201514,8 k €
  10. 2014
    Annual accounts 201414,4 k €
  11. 2013
    Annual accounts 201320,4 k €
  12. 2012
    Annual accounts 201218,5 k €
  13. 2011
    Annual accounts 201116,6 k €
  14. 2010
    Annual accounts 20101,4 k €
  15. 2009
    Annual accounts 200914,7 k €
  16. 2008
    Annual accounts 2008-2,9 k €
  17. 2007
    Annual accounts 200717 k €
  18. 03/07/1992
    IncorporationPublic limited company